Wednesday, July 8, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “CRINETICS PHARMACEUTICALS, INC.”

26 pharma patents match "CRINETICS PHARMACEUTICALS, INC." in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 26
Index total 30,257
Page 1 / 2

Quick answer

This filtered view shows 26 pharmaceutical patents matching "CRINETICS PHARMACEUTICALS, INC." in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

26 results for “CRINETICS PHARMACEUTICALS, INC.” · 30,257 patents in full index Clear search

  1. US 12280046

    Melanocortin subtype-2 receptor (MC2R) antagonist for the treatment of disease

    CRINETICS PHARMACEUTICALS, INC. · Granted Apr 22, 2025 · Expires Apr 17, 2045

    granted

  2. US 12208092

    Compositions and methods for administering paltusotine to patients with hepatic impairment

    CRINETICS PHARMACEUTICALS, INC. · Granted Jan 28, 2025 · Expires Jan 23, 2045

    granted

  3. US 12134610

    Somatostatin subtype-2 receptor (SST2R) targeted therapeutics and uses thereof

    CRINETICS PHARMACEUTICALS, INC. · Granted Nov 5, 2024 · Expires Oct 31, 2044

    granted

  4. US 11957674

    Formulations of a somatostatin modulator

    CRINETICS PHARMACEUTICALS, INC. · Granted Apr 16, 2024 · Expires Apr 11, 2044

    granted

  5. US 11834462

    Somatostatin modulators and uses thereof

    CRINETICS PHARMACEUTICALS, INC. · Granted Dec 5, 2023 · Expires Nov 30, 2043

    granted

  6. US 11773076

    Crystalline forms of a somatostatin modulator

    CRINETICS PHARMACEUTICALS, INC. · Granted Oct 3, 2023 · Expires Sep 28, 2043

    granted

  7. US 11608335

    Somatostatin modulators and uses thereof

    CRINETICS PHARMACEUTICALS, INC. · Granted Mar 21, 2023 · Expires Mar 16, 2043

    granted

  8. US 11566015

    Melanocortin subtype-2 receptor (MC2R) antagonists and uses thereof

    CRINETICS PHARMACEUTICALS, INC. · Granted Jan 31, 2023 · Expires Jan 26, 2043

    granted

  9. US 11479540

    Nonpeptide somatostatin type 5 receptor agonists and uses thereof

    CRINETICS PHARMACEUTICALS, INC. · Granted Oct 25, 2022 · Expires Oct 20, 2042

    granted

  10. US 11414397

    Somatostatin modulators and uses thereof

    CRINETICS PHARMACEUTICALS, INC. · Granted Aug 16, 2022 · Expires Aug 11, 2042

    granted

  11. US 11266641

    Formulations of a somatostatin modulator

    CRINETICS PHARMACEUTICALS, INC. · Granted Mar 8, 2022 · Expires Mar 3, 2042

    granted

  12. US 11186590

    Somatostatin modulators and uses thereof

    CRINETICS PHARMACEUTICALS, INC. · Granted Nov 30, 2021 · Expires Nov 25, 2041

    granted

  13. US 11072598

    Somatostatin modulators and uses thereof

    CRINETICS PHARMACEUTICALS, INC. · Granted Jul 27, 2021 · Expires Jul 22, 2041

    granted

  14. US 11028068

    Somatostatin modulators and uses thereof

    CRINETICS PHARMACEUTICALS, INC. · Granted Jun 8, 2021 · Expires Jun 3, 2041

    granted

  15. US 10981894

    Melanocortin subtype-2 receptor (MC2R) antagonists and uses thereof

    CRINETICS PHARMACEUTICALS, INC. · Granted Apr 20, 2021 · Expires Apr 15, 2041

    granted

  16. US 10889561

    Process of making somatostatin modulators

    CRINETICS PHARMACEUTICALS, INC. · Granted Jan 12, 2021 · Expires Jan 7, 2041

    granted

  17. US 10875839

    Somatostatin modulators and uses thereof

    CRINETICS PHARMACEUTICALS, INC. · Granted Dec 29, 2020 · Expires Dec 24, 2040

    granted

  18. US 10766877

    Melanocortin subtype-2 receptor (MC2R) antagonists and uses thereof

    CRINETICS PHARMACEUTICALS, INC. · Granted Sep 8, 2020 · Expires Sep 3, 2040

    granted

  19. US 10696689

    Somatostatin modulators and uses thereof

    CRINETICS PHARMACEUTICALS, INC. · Granted Jun 30, 2020 · Expires Jun 25, 2040

    granted

  20. US 10604507

    Melanocortin subtype-2 receptor (MC2R) antagonists and uses thereof

    CRINETICS PHARMACEUTICALS, INC. · Granted Mar 31, 2020 · Expires Mar 26, 2040

    granted

  21. US 10597377

    Somatostatin modulators and uses thereof

    CRINETICS PHARMACEUTICALS, INC. · Granted Mar 24, 2020 · Expires Mar 19, 2040

    granted

  22. US 10562884

    Melanocortin subtype-2 receptor (MC2R) antagonists and uses thereof

    CRINETICS PHARMACEUTICALS, INC. · Granted Feb 18, 2020 · Expires Feb 13, 2040

    granted

  23. US 10464918

    Process of making somatostatin modulators

    CRINETICS PHARMACEUTICALS, INC. · Granted Nov 5, 2019 · Expires Oct 31, 2039

    granted

  24. US 10351547

    Somatostatin modulators and uses thereof

    CRINETICS PHARMACEUTICALS, INC. · Granted Jul 16, 2019 · Expires Jul 11, 2039

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.